Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 432-438, May 2010

Extending the Boundaries of Cardiac Resynchronization Therapy: Efficacy in Atrial Fibrillation, New York Heart Association Class II, and Narrow QRS Heart Failure Patients

  • Sara Wein, MBBS, BMEDSC

      Affiliations

    • Alfred Hospital, Melbourne, Australia
    • ,
  • Aleksandr Voskoboinik, MBBS (HONS)

      Affiliations

    • Royal Melbourne Hospital, Melbourne, Australia
    • ,
  • Lironne Wein, MBBS (HONS), BMEDSC (HONS)

      Affiliations

    • Monash Medical Centre, Melbourne, Australia
    • ,
  • Baki Billah, PhD, MAS, MSc, BSc (HONS)

      Affiliations

    • Alfred Hospital, Melbourne, Australia
    • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology & Preventive Medicine, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia
    • ,
  • Henry Krum, MBBS, PhD, FRACP

      Affiliations

    • Alfred Hospital, Melbourne, Australia
    • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology & Preventive Medicine, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia
    • Corresponding Author InformationReprint requests: Professor Henry Krum, MBBS, PhD, FRACP, Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology & Preventive Medicine, Monash University / Alfred Hospital, 89 Commercial Road, Melbourne, Vic 3004, Australia. Tel: +61 3 9903 0042; Fax: +61 3 9903 0556.

Received 6 August 2009; received in revised form 7 November 2009; accepted 21 December 2009. published online 12 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Prof Henry Krum is on the executive committee of the EchoCRT trial, which is sponsored by Biotronik, Inc.

PII: S1071-9164(09)01238-X

doi:10.1016/j.cardfail.2009.12.018

Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 432-438, May 2010

Article Tools

* Image Usage & Resolution